Gouvernance Vertex Pharmaceuticals Incorporated

VRTX

US92532F1003

Produits pharmaceutiques

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 10/07/2026			Après clôture 22:17:29
485,39 ^USD	-2,24 %		492,82	+1,53 %

09/07	VERTEX PHARMACEUTICALS INCORPORATED : RBC Capital Markets conserve son opinion neutre	ZM
08/07	Le secteur biopharmaceutique devrait se recentrer sur les fondamentaux au second semestre, selon Morgan Stanley	MT

Comité Exécutif: Vertex Pharmaceuticals Incorporated

Dirigeant

Fonctions occupéesDepuis

Reshma Kewalramani

53 ans

Chief Executive Officer	01/04/2020
President	01/04/2020

Kristen Ambrose

49 ans

Comptroller/Controller/Auditor

01/03/2021

Agam Upadhyay

Chief Tech/Sci/R&D Officer

01/07/2025

Sean Daughtry

Chief Tech/Sci/R&D Officer

Susie Lisa

Investor Relations Contact

01/09/2022

Jonathan Biller

63 ans

General Counsel

19/09/2022

Edward Atkinson

60 ans

Chief Tech/Sci/R&D Officer

29/08/2023

Mark Bunnage

Chief Tech/Sci/R&D Officer

01/07/2021

Joy Liu

General Counsel	-
Corporate Secretary	-

Nia Tatsis

56 ans

General Counsel

01/09/2017

Carmen Bozic

63 ans

Chief Tech/Sci/R&D Officer

01/04/2020

Charles Wagner

58 ans

Chief Operating Officer	01/07/2025
Director of Finance/CFO	10/04/2019

Stephanie Franklin

Human Resources Officer

01/08/2017

Composition du Conseil d'Administration: Vertex Pharmaceuticals Incorporated

Administrateur

ComitésDepuis

Jeffrey Leiden

70 ans

Executive Committee	01/01/2015
HR Committee	01/01/2015
Governance Committee	01/01/2015
Compensation Committee Chair	01/03/2022
Governance Committee Chair	01/03/2022
Nominating Committee Chair	01/03/2022

Diana McKenzie

61 ans

Audit Committee	17/02/2023
Finance Committee
Compensation Committee	03/06/2020
Governance Committee	03/06/2020
Nominating Committee	03/06/2020
Compensation Committee Chair
HR Committee Chair

Lloyd Carney

64 ans

Audit Committee	21/02/2019
Compensation Committee Chair
Finance Committee	21/02/2019
Governance Committee Chair	04/03/2020
Nominating Committee Chair	04/03/2020
Compensation Committee	04/03/2020

Bruce Sachs

66 ans

Governance Committee
Nominating Committee
Compensation Committee Chair	30/04/2012
Executive Committee

Nancy Thornberry

69 ans

Governance Committee	24/09/2019
Nominating Committee	24/09/2019
Compensation Committee	08/01/2021

Sangeeta Bhatia

57 ans

Governance Committee	18/06/2015
Nominating Committee	18/06/2015

Alan Garber

70 ans

Governance Committee	08/06/2017
Nominating Committee	08/06/2017

Nia Tatsis

56 ans

Governance Committee	01/09/2025
Nominating Committee	01/09/2025

Michel Lagarde

52 ans

Audit Committee	05/10/2023
Finance Committee	05/10/2023

Jennifer Schneider

50 ans

Compensation Committee

15/05/2024

Reshma Kewalramani

53 ans

Director/Board Member

01/03/2020

Dernières Nominations: Vertex Pharmaceuticals Incorporated

29/04	Vertex Pharmaceuticals Incorporated annonce que Suketu Upadhyay ne sollicitera pas le renouvellement de son mandat d'administrateur	CI
14/04	Zealand Pharma A/S annonce la nomination d'Eric Rojas au poste de responsable des relations investisseurs, effective au 15 avril 2026	CI
03/03	Acadia Pharmaceuticals Inc. nomme Jonathan M. Poole au conseil d'administration et au comité d'audit, à compter du 3 mars 2026	CI
03/03	Absci Corporation annonce des changements au sein de son équipe dirigeante	CI
24/02	Helus Pharma nomme Freda Lewis-Hall au conseil d'administration et à la présidence du comité consultatif scientifique	CI
29/01	Satellos Bioscience Inc. nomme Antoinette Paone au poste de Chief Development Officer et responsable des affaires réglementaires	CI
08/01	Praxis Precision Medicines nomme l'ancien PDG de Pfizer Jeffrey Kindler au conseil d'administration et promeut Megan Sniecinski au poste de directrice des opérations	MT

Plus d'Actualités

Anciens Dirigeants et Administrateurs: Vertex Pharmaceuticals Incorporated

Insider

Fonctions occupées

DepuisJusqu'au

Terrence Kearney

Director/Board Member	17/05/2011	15/05/2024
Independent Dir/Board Member	17/05/2011	15/05/2024

Margaret McGlynn

Director/Board Member	12/05/2011	17/05/2023
Independent Dir/Board Member	12/05/2011	17/05/2023

Paul Silva

Comptroller/Controller/Auditor	29/09/2008	01/04/2021
Director of Finance/CFO	23/01/2019	10/04/2019
Corporate Officer/Principal	01/08/2007	28/09/2008

Elaine S. Ullian

Director/Board Member	01/01/1997	05/06/2019
Independent Dir/Board Member	14/07/2011	05/06/2019

Ian Smith

Chief Operating Officer	01/01/2017	23/01/2019
Director of Finance/CFO	13/12/2018	23/01/2019

Joshua Boger

Director/Board Member	01/01/1989	08/06/2017
Founder	01/01/1989	08/06/2017
President	01/01/1989	16/04/2010

Wayne Riley

Director/Board Member	14/07/2010	01/07/2015
Independent Dir/Board Member	14/07/2011	01/07/2015

Peter Mueller

Chief Tech/Sci/R&D Officer

01/07/2003

31/10/2014

Valerie Lynne Andrews

General Counsel

01/01/2002

31/05/2014

Robert Kauffman

Chief Tech/Sci/R&D Officer

22/11/2010

08/01/2014

Christiana Stamoulis

Corporate Officer/Principal

01/11/2010

01/12/2013

Lisa Kelly-Croswell

Human Resources Officer

01/07/2006

01/06/2013

Nancy Wysenski

Corporate Officer/Principal

28/12/2009

12/06/2012

TY Howton

General Counsel	19/12/2011	12/06/2012
Corporate Officer/Principal	05/10/2011	19/12/2011
Corporate Secretary	01/09/2009	12/06/2012

Dennis Winger

Director/Board Member	10/07/2009	-
Independent Dir/Board Member	14/07/2011	-

Amy Pasqua

Public Communications Contact

15/07/2011

01/10/2011

Stuart J. M. Collinson

Director/Board Member	01/01/2002	01/01/2011
Independent Dir/Board Member	01/01/2002	01/01/2011

Charlie Sanders

Director/Board Member	07/05/2010	18/10/2010
Chairman	01/01/1996	07/05/2010

Roger W. Brimblecombe

Director/Board Member

01/01/1993

13/05/2010

Freda Lewis-Hall

Chief Tech/Sci/R&D Officer

01/06/2008

01/05/2009

Kerry Reinertsen

Corporate Officer/Principal

01/01/2004

01/01/2009

Eric Brandt

Director/Board Member

01/01/2003

John Alam

Chief Tech/Sci/R&D Officer

01/10/1997

01/10/2008

Johanna Messina-Power

Comptroller/Controller/Auditor

01/01/1999

12/09/2008

Eve Elizabeth Slater

Director/Board Member

01/01/2004

01/08/2007

Victor A. Hartmann

Corporate Officer/Principal

22/06/2007

Lynne Brum

Public Communications Contact

01/01/1994

Richard C. Garrison

Corporate Officer/Principal

01/12/2005

N. Coles

Corporate Officer/Principal

01/05/2005

01/10/2005

Vicki Sato

Chief Tech/Sci/R&D Officer	01/01/1992	01/01/2000
President	01/01/2000	01/05/2005

Roger Tung

Corporate Officer/Principal

01/01/1989

01/01/2005

Eugene H. Cordes

Director/Board Member	01/01/2005	-
Independent Dir/Board Member	14/07/2011	-

Jeremy Chadwick

Corporate Officer/Principal

01/01/2002

01/05/2004

Iain Peter Murray Buchanan

Corporate Officer/Principal

01/01/1994

Matthew Emmens

Director/Board Member	30/04/2012	-
Chairman	07/05/2010	30/04/2012
President	01/01/2004	02/02/2012

Sean O'Brien

Corporate Officer/Principal

31/05/2002

Thierry Hercend

Corporate Officer/Principal

01/01/1998

01/01/2002

Wei Li

Corporate Officer/Principal

01/01/1998

31/12/2001

Pravin Ramsewak Chaturvedi

Corporate Officer/Principal

01/02/1994

01/08/2001

Sarah Cecil

General Counsel

01/01/1992

01/01/2001

Kenneth S. Boger

General Counsel

01/01/2001

Richard Aldrich

Founder	01/01/1989	01/01/2001
Corporate Officer/Principal	01/01/1989	01/01/2001

Thomas Auchincloss

Director of Finance/CFO	01/01/1994	01/01/2001
Treasurer	01/01/1994	01/01/2001

Manuel A. Navia

Corporate Officer/Principal

01/01/1989

01/01/1997

Michael Partridge

Investor Relations Contact

15/07/2011

Hector J. Gomez

Chief Tech/Sci/R&D Officer

01/01/1992

01/01/1994

Keith S. Ehrlich

Director of Finance/CFO	01/05/1991	01/10/1993
Treasurer	01/05/1991	01/10/1993

Nancy Stuart

Corporate Officer/Principal

Min Zhang Chen

Chief Tech/Sci/R&D Officer

Charles J. Cohen

Corporate Officer/Principal

Pamela J. Fritz

Human Resources Officer

Derek Hodkey

Corporate Officer/Principal

Darshana Zaveri

Corporate Officer/Principal

Mike Walsh

Corporate Officer/Principal

Zachry Barber

Public Communications Contact

18/05/2011

Chun Lin Chen

Corporate Officer/Principal

Lora L. Pike

Public Communications Contact

John F. Niblack

Director/Board Member

Craig Dunbar

Corporate Officer/Principal

Matthew Osborne

Public Communications Contact

31/08/2010

Lee R. Brettman

Corporate Officer/Principal

Ian Robert Silverman

Corporate Officer/Principal

Nagesh Mahanthappa

Corporate Officer/Principal

Justine Koenigsberg

Corporate Officer/Principal

Robert J. Fram

Corporate Officer/Principal

Leland Webster

Director/Board Member

David J. Livingston

Corporate Officer/Principal

Matthew D'Onofrio

Director/Board Member	-	-
Corporate Officer/Principal	-	-

Gregory S. Nagy

Corporate Officer/Principal

Darren Braccia

Corporate Officer/Principal

Kate Bingham

Corporate Officer/Principal

Peter J. Coassin

Corporate Officer/Principal

Ramon Mohanlal

Chief Tech/Sci/R&D Officer

Shin-San Su

Corporate Officer/Principal

Christopher Poulin

Corporate Officer/Principal

Robert Zelle

Corporate Officer/Principal

Vivian Berlin

Corporate Officer/Principal

Johannes van Houte

Comptroller/Controller/Auditor

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme	22
Femme	11

Dont comité exécutif

Homme	9
Femme	4

Dont Administrateurs

Homme	9
Femme	2

Révisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Non

Controverses sur les droits de l'Homme

Non

Controverses Subventions fiscales

Non

Conforme à la finance Islamique

Vertex Pharmaceuticals Incorporated est spécialisé dans la recherche, le développement et la commercialisation de médicaments micromoléculaires destinés notamment au traitement des cancers, des maladies virales, inflammatoires et auto-immunes. La répartition géographique du CA est la suivante : Etats-Unis (62,9%), Europe (28,8%) et autres (8,3%).

Employés

6 400

Secteur

Produits pharmaceutiques

Agenda

Publication des résultats - Q2 2026

Plus d'informations sur la société